Postoperative Analgesia for Fractured Neck of Femur With Periarticular Infiltration of Local Anaesthetic
NCT ID: NCT02057601
Last Updated: 2014-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2013-01-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimal Positioning of Local Anaesthetic in Femoral Nerve Block Prior to Hip Surgery
NCT01527812
PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture
NCT07046052
Minimum Effective Intrathecal Dose of Local Anaesthetic With Fentanyl for Fractured Neck of Femur(Dose Finding Study).
NCT01922622
Dose Finding Study for Continuous Spinal Anaesthesia
NCT01680120
A Dose Finding Study for Pain Relief of a Broken Hip
NCT00926666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In our hospital, surgical fixation of fractured neck of femur is routinely performed under spinal anaesthesia with intrathecal bupivacaine.. This provides excellent conditions for surgery and gives satisfactory analgesia in the early postoperative period. However, clinical observation indicates that a period of inadequate analgesia often occurs after the offset of intrathecal local anaesthetic effect. Wound infiltration with local anaesthetic after total hip and knee replacement has been investigated as an alternative method of postoperative analgesia (4-8).
Hypotheses Perioperative infiltration of the surgical site with levobupivacaine (in addition to standard systemic analgesics) decreases pain during the first day after surgery.
This technique decreases post-operative systemic opioid requirements and the incidence of associated adverse effects To test these hypotheses we propose to carry out a prospective, randomized controlled clinical study in patients undergoing surgical fixation of fractured neck of femur under spinal anaesthesia.
To our knowledge, a study comparing these two techniques has not been performed previously.
Objectives To evaluate the analgesic efficacy of wound infiltration with levobupivacaine local anaesthetic with 1:200,000 epinephrine after the surgical fixation of fractured neck of femur.
Primary outcome measure Quality of analgesia at 12 hours postoperatively as assessed by verbal rating score (VRS) for pain at rest and on movement.
Methodology
Study design: A prospective, randomized clinical trial.(will be registered with Clinicaltrial.com)
Sample size: We performed a power analyis using our own previous published data, VRS (0-10) pain scores on passive movement in the 12th postoperative hour was 4.4(3.3) mean(SD). We consider that a decrease in the VAS for pain (in the intervention group of 50% would be clinically relevant. To reliably answer our question, with a power of 0.8 and a statistical significance of 0.05, we calculate that we will require a minimum of 17 patients in each group.
Patient population: Adult patients ( \> 60 years) undergoing surgical fixation of fractured neck of femur.
Duration of study period: We will monitor patients perioperatively and during the postoperative period for 2 days.
Overall design: With institutional ethical approval and having obtained written informed consent, 40 patients will be randomly allocated to one of two groups using random number tables and a sealed envelope technique. The first group will receive spinal anaesthesia with intrathecal bupivacaine 0.5% 2.0 ml. The second group will receive spinal anaesthesia with intrathecal bupivacaine 0.5% 2.0ml and will receive peri-surgical site infiltration before wound closure with a solution of levobupivacaine 0.5% 2mg/kg body weight with epinephrine made up to a volume of 1.5ml/kg with saline.
Both groups will be prescribed regular postoperative analgesia of paracetamol 1g qds PO/PR and diclofenac 75mg bd PO. Oxycodone ('Oxynorm') 5-10mg PO qds/prn will also be prescribed. Cyclizine 50 mg i.m. prn/tds will be prescribed for nausea and vomiting. If necessary, ondansetron 4 - 8mg i.v. prn/qds will be administered as a rescue anti-emetic.
The patients will be assessed at 2, 6, 12, 24 and 48 hours postoperatively. We will assess severity of pain using VRS at rest and on passive movement of the operative hip joint, cumulative morphine consumption, quality of analgesia during early mobilisation, compliance with physiotherapy, and adverse effects associated with opioid administration, \[(i) sedation (1, awake; 2-drowsy; 3-asleep, easily rousable; 4-asleep, hard to rouse), (ii) incidence and severity of postoperative nausea (0 - no nausea, 1 - complaints of nausea but tolerable, 2 - needs cyclizine 50 mg i.m.), (iii) respiratory depression (ventilatory frequency less than 8 min-1); (iv) pruritus (1-no itch; 2-itching but tolerable; 3-severe itch needs piriton 5 mg i.m.); (v) urinary retention (C- catheterized electively postoperatively; N-no catheter required; R-catheter sited because of urinary retention)\]. Patients will be asked to rate their satisfaction with perioperative pain management ( on 0-10 VRS) and whether they would have the same pain therapy again.
Statistical Analysis Collected data will be examined for normality. Quantitative data e.g. analgesic consumption and visual analog pain scores will be examined using the Student-t test. Categorical data will be examined using the chi-squared test. Fisher's Exact test will be used to compare non-parametric data (i.e. necessity of a urinary catheter). P\<0.05 will be considered significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infiltration group
The patients in this group will receive spinal anaesthesia with intrathecal bupivacaine 0.5% 2.0ml and will receive peri-surgical site infiltration before wound closure with a solution of levobupivacaine 0.5% 2mg/kg body weight with epinephrine made up to a volume of 1.5ml/kg with saline.
Levobupivacaine infiltration group
The patients in the intervention group will receive peri-surgical site infiltration before wound closure with a solution of levobupivacaine 0.5% 2mg/kg body weight with epinephrine made up to a volume of 1.5ml/kg with saline.
Non infiltration group
The patients in this group will receive spinal anaesthesia with intrathecal bupivacaine 0.5% 2.0 ml.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Levobupivacaine infiltration group
The patients in the intervention group will receive peri-surgical site infiltration before wound closure with a solution of levobupivacaine 0.5% 2mg/kg body weight with epinephrine made up to a volume of 1.5ml/kg with saline.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* consent to spinal anaesthesia
* ASA grade 1-3
Exclusion Criteria
* Mini mental scores less than 25
* Allergy to bupivacaine, morphine, paracetamol and diclofenac
* Skin lessons/ infections at the site of injection
* Uncorrected renal dysfunction
* Coagulation disorders
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cork University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Szilard Szucs
Clinical Lecturer in Anaesthesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cork University Hospital
Cork, Cork, Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECM 4 (zz) 09/04/13
Identifier Type: OTHER
Identifier Source: secondary_id
ECM4 (zz) 09/04/13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.